Xiaodong Peng
Research Subjects
Research Interests
Xiaodong Peng has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Wei Shan
Southern Univ Sci & Technol, Affiliated Mental Hlth Ctr, Shenzhen, Guangdong, Peoples R China
2 shared publicationsZhijian Zhou
Southern Univ Sci & Technol, Affiliated Mental Hlth Ctr, Shenzhen, Guangdong, Peoples R China
2 shared publicationsEd F. van Beeck
Erasmus MC, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
1 shared publicationGuojun Wang
Southern Univ Sci & Technol, Affiliated Mental Hlth Ctr, Shenzhen, Guangdong, Peoples R China
1 shared publicationHaiyan Xie
Affiliated Mental Health Center, Southern University of Science and Technology, China; Department of Public Health, Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
1 shared publication- Jan Hendrik Richardus
Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 7 November 2024
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 27 (1) , e227
Prevalence of and factors associated with overweight and obesity in patients with severe mental disorders in Shenzhen: results from the urban Chinese population
Objective: To determine the prevalence of overweight and obesity in patients with severe mental disorders (SMD) and the factors associated with their socio-demographic and disease characteristics in a cross-sectional population-based study. Design: This analysis examined the prevalence of overweight and obesity in 14 868 managed SMD patients in an urban area of Shenzhen city based on data from the health information monitoring system in 2021. Multivariate logistic regression were used to identify the factors associated with the prevalence of overweight and obesity in patients with SMD. Setting: China. Participants: 14 868 patients with SMD. Results: The prevalence of overweight and obesity in patients with SMD in this study was 32·6 % and 16·1 %, respectively. In multivariate analysis, married status, Shenzhen household registration, management durations of 5–10 years and >10 years, participation in family physician services, taking clozapine or aripiprazole, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of overweight and obesity. Compared to their respective reference categories, living with parents, spouse and children, taking risperidone, aripiprazole, amisulpride and perphenazine, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of obesity. Conclusion: We observed a high prevalence of overweight and obesity in patients with SMD in this study. The findings highlight the need for integrated management of overweight and obesity risk factors among patients with SMD.
- 7 November 2024
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 27 (1) , e227
Open AccessPrevalence of and factors associated with overweight and obesity in patients with severe mental disorders in Shenzhen: results from the urban Chinese population
Objective: To determine the prevalence of overweight and obesity in patients with severe mental disorders (SMD) and the factors associated with their socio-demographic and disease characteristics in a cross-sectional population-based study. Design: This analysis examined the prevalence of overweight and obesity in 14 868 managed SMD patients in an urban area of Shenzhen city based on data from the health information monitoring system in 2021. Multivariate logistic regression were used to identify the factors associated with the prevalence of overweight and obesity in patients with SMD. Setting: China. Participants: 14 868 patients with SMD. Results: The prevalence of overweight and obesity in patients with SMD in this study was 32·6 % and 16·1 %, respectively. In multivariate analysis, married status, Shenzhen household registration, management durations of 5–10 years and >10 years, participation in family physician services, taking clozapine or aripiprazole, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of overweight and obesity. Compared to their respective reference categories, living with parents, spouse and children, taking risperidone, aripiprazole, amisulpride and perphenazine, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of obesity. Conclusion: We observed a high prevalence of overweight and obesity in patients with SMD in this study. The findings highlight the need for integrated management of overweight and obesity risk factors among patients with SMD.
- 1 February 2024
- Published by Elsevier in Sleep Medicine
- Vol. 115, 39-47
Prevalence of insomnia and associations with depression, anxiety among adults in guangdong, China: A large-scale cross-sectional study
- 1 February 2024
- Published by Elsevier in Sleep Medicine
- Vol. 115, 39-47
Prevalence of insomnia and associations with depression, anxiety among adults in guangdong, China: A large-scale cross-sectional study
- Open Access
- 1 January 2019
- Published by Elsevier in Journal of Infection
- Vol. 78 (1) , 19-26
A hand hygiene intervention to decrease hand, foot and mouth disease and absence due to sickness among kindergarteners in China: A cluster-randomized controlled trial
- 1 January 2019
- Published by Elsevier in Journal of Infection
- Vol. 78 (1) , 19-26
Open AccessA hand hygiene intervention to decrease hand, foot and mouth disease and absence due to sickness among kindergarteners in China: A cluster-randomized controlled trial